Nonvalvular Cardiovascular Device–Related Infections

More than a century ago, Osler took numerous syndrome descriptions of cardiac valvular infection that were incomplete and confusing and categorized them into the cardiovascular infections known as infective endocarditis. Because he was both a clinician and a pathologist, he was able to provide a meaningful outline of this complex disease. Technical advances have allowed us to better subcategorize infective endocarditis on the basis of microbiological etiology. More recently, the syndromes of infective endocarditis and endarteritis have been expanded to include infections involving a variety of cardiovascular prostheses and devices that are used to replace or assist damaged or dysfunctional tissues (Table 1). Taken together, infections of these novel intracardiac, arterial, and venous devices are frequently seen in medical centers throughout the developed world. In response, the American Heart Association’s Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease wrote this review to assist and educate clinicians who care for an increasing number of patients with nonvalvular cardiovascular device–related infections. Because timely guidelines1,2 exist that address the prevention and management of intravascular catheter–related infections, these device-related infections are not discussed in the present Statement. View this table: TABLE 1. Nonvalvular Cardiovascular Device–Related Infections This review is divided into two broad sections. The first section examines general principles for the evaluation and management of infection that apply to all nonvalvular cardiovascular devices. Despite the marked variability in composition, structure, function, and frequency of infection among the various types of nonvalvular cardiovascular devices reviewed in this article, there are several areas of commonality for infection of these devices. These include clinical manifestations, microbiology, pathogenesis, diagnosis, treatment, and prevention. The second section addresses each device and describes unique clinical features of infection. Each device is placed into one of 3 categories—intracardiac, arterial, or venous—for discussion. ### Clinical Manifestations The specific signs and symptoms associated with an infection of a …

[1]  Walter R Wilson,et al.  Nonvalvular cardiovascular device-related infections. , 2004, Clinical Infectious Diseases.

[2]  D. Kovacevich,et al.  Guidelines for the prevention of intravascular catheter-related infections: Centers for Disease Control and Prevention. , 2003, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[3]  C. Brun-Buisson,et al.  Nosocomial infections occurring during receipt of circulatory support with the paracorporeal ventricular assist system. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  E. D’Agata Antimicrobial-resistant, Gram-positive bacteria among patients undergoing chronic hemodialysis. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  J. Adis,et al.  Gladiators: a new order of insect. , 2002, Scientific American.

[6]  G. Nassar,et al.  Infectious complications of old nonfunctioning arteriovenous grafts in renal transplant recipients: a case series. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  M. Back,et al.  Management of Vascular Complications following Femoral Artery Catheterization with and without Percutaneous Arterial Closure Devices , 2002, Annals of vascular surgery.

[8]  L. Baddour,et al.  Nonvalvular intravascular device-related infections , 2002, Current infectious disease reports.

[9]  J. Tokars,et al.  New national surveillance system for hemodialysis-associated infections: initial results. , 2002, American journal of infection control.

[10]  S. Ditlea The trials of an artificial heart. , 2002, Scientific American.

[11]  P. Malani,et al.  Nosocomial infections in left ventricular assist device recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  V. Parsonnet,et al.  Prophylactic Antibiotics Prior to Bacteremia Decrease Endovascular Graft Infection in Dogs , 2002, Vascular and endovascular surgery.

[13]  A. Bolger,et al.  Unique features of infective endocarditis in childhood. , 2002, Pediatrics.

[14]  A. Bolger,et al.  Unique features of infective endocarditis in childhood. , 2002, Circulation.

[15]  M. V. van Sambeek,et al.  Management of aortic graft infection. , 2002, The Journal of cardiovascular surgery.

[16]  M. Shive,et al.  Shear stress and material surface effects on adherent human monocyte apoptosis. , 2002, Journal of biomedical materials research.

[17]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[18]  U. Steger,et al.  Surgical management of prosthetic vascular graft infection: comparative retrospective analysis of 30 consecutive cases. , 2002, VASA. Zeitschrift fur Gefasskrankheiten.

[19]  T. Sundt,et al.  Infective endocarditis resulting from CardioSEAL closure of a patent foramen ovale , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[20]  D. Hudson,et al.  The Effectiveness of Muscle Flaps for the Treatment of Prosthetic Graft Sepsis , 2002, Plastic and reconstructive surgery.

[21]  J. Duggan,et al.  Left Ventricular Assist Device Infections: Three Case Reports and a Review of the Literature , 2002, ASAIO journal.

[22]  G. Oderich,et al.  Aortic Graft Infection What Have we Learned During the Last Decades ? , 2002, Acta chirurgica Belgica.

[23]  S. Kachboura,et al.  [Pacemaker infections]. , 2002, La Tunisie medicale.

[24]  P. Lang,et al.  Closing ventricular septal defects in the cardiac catheterization laboratory. , 2002, Heart disease.

[25]  G. Moran,et al.  Staphylococcus aureus resistant to vancomycin--United States, 2002. , 2002, MMWR. Morbidity and mortality weekly report.

[26]  J. Eidt,et al.  Infectious complications resulting from use of hemostatic puncture closure devices. , 2001, American journal of surgery.

[27]  M. Bell Biofilms: A clinical perspective , 2001, Current infectious disease reports.

[28]  J. Elmore,et al.  Femoral artery infections associated with percutaneous arterial closure devices. , 2001, Journal of vascular surgery.

[29]  R. J. Valentine,et al.  Diagnosis and management of aortic graft infection. , 2001, Seminars in vascular surgery.

[30]  R. Donlan Biofilm formation: a clinically relevant microbiological process. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  J. Keaney Grossman's cardiac catheterization, angiography, and intervention, 6th ed , 2001 .

[32]  L. Danziger,et al.  Antimicrobial-Coated/Bonded and -Impregnated Intravascular Catheters , 2001, The Annals of pharmacotherapy.

[33]  J. Ruskin,et al.  Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implants. , 2001, The American journal of cardiology.

[34]  P. François,et al.  Reassessing the Role of Staphylococcus aureus Clumping Factor and Fibronectin-Binding Protein by Expression in Lactococcus lactis , 2001, Infection and Immunity.

[35]  L. Baddour Long‐Term Suppressive Antimicrobial Therapy for Intravascular Device‐Related Infections , 2001, The American journal of the medical sciences.

[36]  J. Delcán,et al.  Bloodstream infections after invasive nonsurgical cardiologic procedures. , 2001, Archives of internal medicine.

[37]  R M Nerem,et al.  Endothelial cellular response to altered shear stress. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[38]  K. Jenkins,et al.  Healing response to the clamshell device for closure of intracardiac defects in humans , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[39]  M. Back,et al.  Expanded application of in situ replacement for prosthetic graft infection. , 2001, Journal of vascular surgery.

[40]  Vance G. Fowler,et al.  Staphylococcus aureus Bacteremia in Patients With Permanent Pacemakers or Implantable Cardioverter-Defibrillators , 2001, Circulation.

[41]  A. Cheung,et al.  Adherence Properties of Staphylococcus aureus under Static and Flow Conditions: Roles of agrand sar Loci, Platelets, and Plasma Ligands , 2001, Infection and Immunity.

[42]  J. O’Gara,et al.  Staphylococcus epidermidis biofilms: importance and implications. , 2001, Journal of medical microbiology.

[43]  G. Nassar,et al.  Infectious complications of the hemodialysis access. , 2001, Kidney international.

[44]  Bunt Tj Vascular graft infections: an update. , 2001 .

[45]  T. Bunt Vascular Graft Infections: An Update , 2001, Cardiovascular surgery.

[46]  M. T. Sykes,et al.  Changing Pattern of Access Site Complications with the Use of Percutaneous Closure Devices , 2001, Vascular surgery.

[47]  L. Mermel,et al.  Guidelines for the Management of Intravascular Catheter-Related Infections , 2001, Infection Control & Hospital Epidemiology.

[48]  D. Botta,et al.  The management of peripheral vascular complications associated with the use of percutaneous suture-mediated closure devices. , 2001, Journal of vascular surgery.

[49]  H. Dosluoglu,et al.  Stent-Related Iliac Artery and Iliac Vein Infections: Two Unreported Presentations and Review of the Literature , 2001, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[50]  F. Bracke,et al.  Pacemaker lead complications: when is extraction appropriate and what can we learn from published data? , 2001, Heart.

[51]  W. C. Sternbergh Regarding "Dacron carotid patch infection: a report of eight cases". , 2001, Journal of vascular surgery.

[52]  M. Oz,et al.  Induction of T-cell apoptosis by polyurethane biomaterials used in left ventricular assist devices is dependent on calcineurin activation. , 2001, Transplantation proceedings.

[53]  S Itescu,et al.  Induction of CD40 ligand expression in human T cells by biomaterials derived from left ventricular assist device surface. , 2001, Transplantation proceedings.

[54]  H. Scheld,et al.  Immunologic effects of implantation of left ventricular assist devices. , 2001, Transplantation proceedings.

[55]  P. Grossi,et al.  Infectious complications in patients with the Novacor left ventricular assist system. , 2001, Transplantation proceedings.

[56]  H. Scheld,et al.  Immune response in the early postoperative period after implantation of a left-ventricular assist device system. , 2001, Transplantation proceedings.

[57]  D. Raoult,et al.  Endocarditis Due to Rare and Fastidious Bacteria , 2001, Clinical Microbiology Reviews.

[58]  C. Moore,et al.  Complications of femoral artery closure devices , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[59]  E. Mylonakis,et al.  Infective endocarditis in adults. , 2001, The New England journal of medicine.

[60]  N. Aronson,et al.  Infected endovascular stents managed with medical therapy alone , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[61]  M. Oz,et al.  Infections During Left Ventricular Assist Device Support Do Not Affect Posttransplant Outcomes , 2000, Circulation.

[62]  L. Horn,et al.  Successful retrieval of infected Günther Tulip IVC filter. , 2000, Journal of vascular and interventional radiology : JVIR.

[63]  David Longworth,et al.  Diagnosis and Management of Infections Involving Implantable Electrophysiologic Cardiac Devices , 2000, Annals of Internal Medicine.

[64]  S. Gillespie,et al.  Comparison of fitness of two isolates of Mycobacterium tuberculosis, one of which had developed multi-drug resistance during the course of treatment. , 2000, The Journal of infection.

[65]  N. Hertzer,et al.  Dacron carotid patch infection: a report of eight cases. , 2000, Journal of vascular surgery.

[66]  S. Usami,et al.  Molecular mechanism of endothelial growth arrest by laminar shear stress. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[67]  S Itescu,et al.  Immunobiology of left ventricular assist devices. , 2000, Progress in cardiovascular diseases.

[68]  R. Körfer,et al.  Complications of circulatory assist , 2000, Perfusion.

[69]  J. Fidler,et al.  Aortic prosthetic graft infections: radiologic manifestations and implications for management. , 2000, Radiographics : a review publication of the Radiological Society of North America, Inc.

[70]  John M. Tarbell,et al.  Interaction between Wall Shear Stress and Circumferential Strain Affects Endothelial Cell Biochemical Production , 2000, Journal of Vascular Research.

[71]  M. Höök,et al.  The Fibronectin-binding MSCRAMM FnbpA ofStaphylococcus aureus Is a Bifunctional Protein That Also Binds to Fibrinogen* , 2000, The Journal of Biological Chemistry.

[72]  D. Grove,et al.  Efficacy of long-term antibiotic suppressive therapy in proven or suspected infected abdominal aortic grafts. , 2000, Journal of Infection.

[73]  A. Miller,et al.  Infectious complications related to the use of the Angio‐Seal hemostatic puncture closure device , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[74]  R. Erbel,et al.  Infectious complications related to the use of the Angio‐Seal hemostatic puncture closure device , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[75]  Seeger Jm Management of patients with prosthetic vascular graft infection. , 2000 .

[76]  P. Eggimann,et al.  Pacemaker and Defibrillator Infections , 2000 .

[77]  D. Haas,et al.  Antimicrobial Prophylaxis of Infections Associated with Foreign Bodies , 2000 .

[78]  J. Seeger Management of Patients with Prosthetic Vascular Graft Infection , 2000, The American surgeon.

[79]  S. Alper,et al.  Hemodynamic shear stress and its role in atherosclerosis. , 1999, JAMA.

[80]  M. Oz,et al.  Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95. , 1999, Circulation.

[81]  S. Cramton,et al.  The Intercellular Adhesion (ica) Locus Is Present in Staphylococcus aureus and Is Required for Biofilm Formation , 1999, Infection and Immunity.

[82]  J M Anderson,et al.  Shear stress effects on bacterial adhesion, leukocyte adhesion, and leukocyte oxidative capacity on a polyetherurethane. , 1999, Journal of biomedical materials research.

[83]  R. Welling,et al.  Infectibility of endovascular stents following antibiotic prophylaxis or after arterial wall incorporation. , 1999, American journal of surgery.

[84]  Silviu Itescu,et al.  Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist de vice , 1999, The Lancet.

[85]  R. Benza,et al.  Infection during circulatory support with ventricular assist devices. , 1999, The Annals of thoracic surgery.

[86]  J. Robin,et al.  Video-assisted tricuspid valve surgery: a new surgical option in endocarditis on pacemaker. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[87]  O. Berenfeld,et al.  Cardiopulmonary interactions after Fontan operations. , 1999, Circulation.

[88]  Y. Han,et al.  New self‐expanding patent foramen ovale occlusion device , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[89]  M. Turina,et al.  Management of infected aortic grafts: development of less invasive surgery using cryopreserved homografts. , 1999, The Annals of thoracic surgery.

[90]  T. Deneke,et al.  Suppurative pancarditis: a lethal complication of coronary stent implantation , 1999, Heart.

[91]  M. Kerstein,et al.  Management of Vascular Prosthetic Infections: Results of Long-Term Follow-up , 1999, The American surgeon.

[92]  T. Horan,et al.  Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. , 1999, American journal of infection control.

[93]  Teresa C. Horan,et al.  Guideline for Prevention of Surgical Site Infection, 1999 , 1999, Infection Control & Hospital Epidemiology.

[94]  A. Irvine,et al.  Infection of endovascular stents: an uncommon but important complication. , 1999, Cardiovascular surgery.

[95]  S. Menahem,et al.  Infective endocarditis on an occluder closing an atrial septal defect , 1999, Cardiology in the Young.

[96]  H Le Breton,et al.  Pacemaker lead infection: echocardiographic features, management, and outcome , 1999, Heart.

[97]  T. Horan,et al.  Guideline for prevention of surgical site infection. , 2000, Bulletin of the American College of Surgeons.

[98]  Ò. Miró,et al.  Pacemaker-Related Endocarditis , 1999, Cardiology.

[99]  P. Holme,et al.  Shear-induced platelet activation and platelet microparticle formation in native human blood. , 1998, Thrombosis research.

[100]  G. Lamas,et al.  Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads. , 1998, The American journal of cardiology.

[101]  R. Kontermann,et al.  Cloning and recombinant expression of mouse coagulation factor X. , 1998, Thrombosis research.

[102]  A. Pavie,et al.  Pacemaker infective endocarditis. , 1998, The American journal of cardiology.

[103]  K. K. Lai,et al.  Infections associated with implantable cardioverter defibrillators placed transvenously and via thoracotomies: epidemiology, infection control, and management. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[104]  T. Jikuya,et al.  Prevention of pulmonary embolization during excision of an infected venous thrombus. , 1998, The Thoracic and cardiovascular surgeon.

[105]  A. Natale,et al.  Causes and consequences of discontinuation of the implantable cardioverter-defibrillator therapy in non-terminally ill patients. , 1998, The American journal of cardiology.

[106]  K Isaaz,et al.  Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. , 1998, Circulation.

[107]  E. Sideris,et al.  Intermediate-term results of Phase I Food and Drug Administration Trials of buttoned device occlusion of secundum atrial septal defects. , 1998, Journal of the American College of Cardiology.

[108]  A. Garson,et al.  Pediatric therapeutic cardiac catheterization: a statement for healthcare professionals from the Council on Cardiovascular Disease in the Young, American Heart Association. , 1998, Circulation.

[109]  Ò. Miró,et al.  Pacemaker-related endocarditis. Report of 7 cases and review of the literature. , 1998, Cardiology.

[110]  L. Latson Per-Catheter ASD Closure , 1998, Pediatric Cardiology.

[111]  J. Berland,et al.  Pseudomonas aeruginosa coronary stent infection. , 1997, The Annals of thoracic surgery.

[112]  M. Oz,et al.  The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. , 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[113]  A F Bolger,et al.  Prevention of bacterial endocarditis. Recommendations by the American Heart Association. , 1997, Circulation.

[114]  D Lacroix,et al.  Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. , 1997, Circulation.

[115]  M H Samore,et al.  Frequency, risk factors, and outcome for bacteremia after percutaneous transluminal coronary angioplasty. , 1997, The American journal of cardiology.

[116]  H. Scheld,et al.  Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. , 1997, Circulation.

[117]  P. Pairolero,et al.  Graft-related complications after abdominal aortic aneurysm repair: reassurance from a 36-year population-based experience. , 1997, Journal of vascular surgery.

[118]  G. Trenholme,et al.  Infectious complications in left ventricular assist device recipients. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[119]  A. Prat,et al.  Fatal infection of coronary stent implantation. , 1996, Catheterization and cardiovascular diagnosis.

[120]  T. Myers,et al.  Retrospective analysis of infection in patients undergoing support with left ventricular assist systems. , 1996, ASAIO journal.

[121]  R. Vogelzang,et al.  Endovascular infection after renal artery stent placement. , 1996, Journal of vascular and interventional radiology : JVIR.

[122]  A. Heimdahl,et al.  Collagen binding of Staphylococcus aureus is a virulence factor in experimental endocarditis. , 1996, The Journal of infectious diseases.

[123]  D. Mack,et al.  Molecular basis of intercellular adhesion in the biofilm‐forming Staphylococcus epidermidis , 1996, Molecular microbiology.

[124]  P. McCarthy,et al.  Implantable LVAD infections: implications for permanent use of the device. , 1996, The Annals of thoracic surgery.

[125]  A. Bisno,et al.  Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. , 1995, JAMA.

[126]  P. François,et al.  Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis , 1995, Infection and immunity.

[127]  M. Oz,et al.  Fungal Infections in Left Ventricular Assist Device Recipients: Incidence, Prophylaxis, and Treatment , 1995, ASAIO journal.

[128]  B. Cunha,et al.  Bacteremia associated with percutaneous transluminal coronary angioplasty. , 1995, Catheterization and cardiovascular diagnosis.

[129]  H. Trappe,et al.  Infections after cardioverter-defibrillator implantation: observations in 335 patients over 10 years. , 1995, British heart journal.

[130]  M. Gilchrist Recommendations for Preventing the Spread of Vancomycin Resistance , 1995, Infection Control & Hospital Epidemiology.

[131]  S. Einav,et al.  Transition to turbulence in pulsatile flow through heart valves--a modified stability approach. , 1994, Journal of biomechanical engineering.

[132]  I. Lossos,et al.  Pacemaker endocarditis. Report of 44 cases and review of the literature. , 1994, Medicine.

[133]  G. Hausdorf,et al.  International experience with secundum atrial septal defect occlusion by the buttoned device. , 1994, American heart journal.

[134]  I Vilacosta,et al.  Impact of Left Ventricular Structure on the Incidence of Hypertension: The Framingham Heart Study , 1994 .

[135]  R. Wenzel,et al.  Quality Standard for Antimicrobial Prophylaxis in Surgical Procedures , 1994, Infection Control & Hospital Epidemiology.

[136]  D. Moher,et al.  LGM (Vena Tech) vena caval filter: experience at a single institution. , 1994, Journal of vascular and interventional radiology : JVIR.

[137]  M. Hravnak,et al.  Management of chronic left ventricular assist device percutaneous lead insertion sites. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[138]  T. Bonzel,et al.  [Coronary stent implantation: infection and abscess with fatal outcome]. , 1993, Zeitschrift fur Kardiologie.

[139]  D. Pittet,et al.  Fibronectin is more active than fibrin or fibrinogen in promoting Staphylococcus aureus adherence to inserted intravascular catheters. , 1993, The Journal of infectious diseases.

[140]  P. Ferrieri,et al.  Laboratory diagnostic methods for central nervous system infections. , 1992, Neurosurgery clinics of North America.

[141]  B. Guglielmo,et al.  ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. ASHP Commission on Therapeutics. , 1992, Clinical pharmacy.

[142]  J. Fehrenbacher,et al.  Septic complications after cardiac catheterization and percutaneous transluminal coronary angioplasty. , 1991, Journal of vascular surgery.

[143]  T. Myers,et al.  Frequency and significance of infections in patients receiving prolonged LVAD support. , 1991, ASAIO transactions.

[144]  D. Pennington,et al.  Device related infections in patients supported with mechanical circulatory support devices for greater than 30 days. , 1991, ASAIO transactions.

[145]  L. Ong,et al.  Local infection after percutaneous transluminal coronary angioplasty: relation to early repuncture of ipsilateral femoral artery. , 1989, Catheterization and cardiovascular diagnosis.

[146]  B. Griffith,et al.  Infections and thromboembolism with implantable cardiovascular devices. , 1989, ASAIO transactions.

[147]  A. Pavie,et al.  Total artificial heart: survival and complications. , 1989, The Annals of thoracic surgery.

[148]  F. Loop,et al.  Infections of the cardiac suture line after left ventricular surgery. , 1988, The American journal of medicine.

[149]  W. Rutala,et al.  An outbreak of Pseudomonas cepacia bacteremia associated with a contaminated intra-aortic balloon pump. , 1988, The Journal of thoracic and cardiovascular surgery.

[150]  R L Kormos,et al.  The artificial heart: infection-related morbidity and its effect on transplantation. , 1988, The Annals of thoracic surgery.

[151]  L. Rice,et al.  Artificial heart implantation: what limitations are imposed by infectious complications? , 1988, JAMA.

[152]  M. Rubenfire,et al.  Intraaortic balloon pump insertion: a randomized study comparing percutaneous and surgical techniques. , 1987, Journal of the American College of Cardiology.

[153]  L. R. Freedman The pathogenesis of infective endocarditis. , 1987, The Journal of antimicrobial chemotherapy.

[154]  M. Rubenfire,et al.  Intraaortic balloon pumping 1967 through 1982: analysis of complications in 733 patients. , 1986, The American journal of cardiology.

[155]  G. Magovern,et al.  Is percutaneous insertion of the intra-aortic balloon pump through the femoral artery the safest technique? , 1986, Journal of vascular surgery.

[156]  G. Bluhm Pacemaker infections. A clinical study with special reference to prophylactic use of some isoxazolyl penicillins. , 2009, Acta medica Scandinavica. Supplementum.

[157]  E. B. Carlson,et al.  Interventional cardiac catheterization. , 1985, Investigative radiology.

[158]  H. Bolooki Current status of circulatory support with an intra-aortic balloon pump. , 1985, Cardiology clinics.

[159]  D. Bandyk,et al.  Aortofemoral graft infection due to Staphylococcus epidermidis. , 1984, Archives of surgery.

[160]  J. Vildé,et al.  [Lumbar spondylodiscitis after insertion of a Mobin-Uddin caval "umbrella" filter (author's transl)]. , 1981, La Nouvelle presse medicale.

[161]  C. Marseille Antimicrobial prophylaxis for surgery. , 1981, The Medical letter on drugs and therapeutics.

[162]  D. Maki,et al.  Infections Caused by Arterial Catheters Used for Hemodynamic Monitoring , 1980 .

[163]  V L Gott,et al.  Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. , 1980, The New England journal of medicine.

[164]  C. Friedman,et al.  Pyrogenic reactions after inadvertent infusion of endotoxin during cardiac catheterizations. , 1980, Annals of internal medicine.

[165]  L. Edmunds,et al.  The Intraaortic Balloon Pump: An Analysis of Five Years' Experience , 1980 .

[166]  J. C. Norman,et al.  Treatment of postoperative low output syndrome with intraaortic balloon pumping: experience with 419 patients. , 1980, The American journal of cardiology.

[167]  W. Casarella,et al.  Percutaneous intraaortic balloon pumping: initial clinical experience. , 1980, The Annals of thoracic surgery.

[168]  S. I. Cohen,et al.  Medically refractory unstable angina pectoris. I. Long-term follow-up of patients undergoing intraaortic balloon counterpulsation and operation. , 1979, The American journal of cardiology.

[169]  V. Subramanian,et al.  Complications of Intra-aortic Balloon Insertion and Counterpulsation , 1978, Circulation.

[170]  R. Mabel,et al.  Complications of intra-aortic balloon insertion and counterpulsation. , 1978 .

[171]  A. Baue,et al.  Results and complications of intraaortic balloon counterpulsation. , 1977, The Annals of thoracic surgery.

[172]  M. Levison,et al.  Sustained bacteremia and transvenous cardiac pacemakers. , 1975, JAMA.

[173]  T. Nealon,et al.  Four hundred consecutive patients with permanent transvenous pacemakers. , 1975, The Journal of thoracic and cardiovascular surgery.

[174]  H. Gold,et al.  Intraaortic Balloon Pumping for Ventricular Septal Defect or Mitral Regurgitation Complicating Acute Myocardial Infarction , 1973, Circulation.

[175]  A. Kantrowitz,et al.  Clinical and Hemodynamic Results of Intraaortic Balloon Pumping and Surgery for Cardiogenic Shock , 1972, Circulation.

[176]  I. Schwartz,et al.  Bacterial endocarditis associated with a permanent transvenous cardiac pacemaker. , 1971, JAMA.

[177]  G. Rowe Complications of cardiac catheterization. , 1971, Wisconsin medical journal.

[178]  Swan Hj Complications of cardiac catheterization. , 1968, Cardio-vascular nursing.

[179]  A Kantrowitz,et al.  Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. , 1968, JAMA.

[180]  Jane M. KUYPERSlt,et al.  Reduced Adherence to Traumatized Rat Heart Valves by a Low-Fibronectin-Binding Mutant of Staphylococcus aureus , 2022 .